Dennis Liotta is Director at ACHILLION PHARMACEUTICALS INC (ACHN). They have made 7 open-market trades across 1 company since 2009, most recently 2013-11-22.
CIK 0001448270
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
7 open-market purchases totalling $502K since 2009, never a sale. Across 7 scored buys the stock is down 1.9% at ninety days, and 2.2 points behind the S&P over the same stretch.
7 scored purchases · one row per filing · discretionary only
| Ticker | Shares | Value |
|---|---|---|
| ACHN | 100,000 | $676K |
Shares reported on the most recent Form 4, priced at the 2013-11-22 close.
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 0% | 0% | 0% |
| Avg Move | -25.7% | -1.9% | -1.9% |
| Alpha | -19.9% | -2.2% | -2.2% |
| Scored | 7 | 7 | 7 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ACHN | BUY | 2013-11-22 | 2013-11-22 | $2.98 | $30K | -25.7% | -1.9% | -1.9% |
| ACHN | BUY | 2013-08-12 | 2013-08-13 | $6.47 | $32K | -25.7% | -1.9% | -1.9% |
| ACHN | BUY | 2013-06-03 | 2013-06-04 | $7.91 | $158K | -25.7% | -1.9% | -1.9% |
| ACHN | BUY | 2012-06-11 | 2012-06-13 | $6.20 | $124K | -25.7% | -1.9% | -1.9% |
| ACHN | BUY | 2011-11-21 | 2011-11-21 | $5.96 | $30K | -25.7% | -1.9% | -1.9% |
| ACHN | BUY | 2011-08-22 | 2011-08-23 | $5.39 | $54K | -25.7% | -1.9% | -1.9% |
| ACHN | BUY | 2009-09-21 | 2011-03-04 | $2.45 | $74K | -25.7% | -1.9% | -1.9% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.